Central Line-Associated Bloodstream Infections (CLABSI)
bloodstream infections (CLABSI) are serious infections that can result in
longer hospital stays, increased costs and increased risk of death. These
infections are among the most deadly types of healthcare-associated infections
with a mortality rate of 12 percent to 25 percent. Experts estimate that the
average cost of care for a patient with CLABSI is $45,000 with an estimated $2
billion annual cost to the U.S. health care system.
Great strides have been
made in U.S. hospitals to prevent CLABSI in the intensive care unit (ICU) with
the use of proper techniques to insert and manage the central line. There is
room to strengthen CLABSI prevention outside of the ICU, however. The Centers for
Disease Control and Prevention estimate that 32 percent of CLABSI in hospitals
occur outside of the ICU.
Download the CLABSI road map.
The CLABSI road map covers central line insertion, maintenance and monitoring, and is intended to be used in all patient care areas in acute care hospitals. The
CLABSI toolkit below is a collection of supporting documents, resources and
tools to assist hospitals in implementing the bundle.
For more information, contact the MHA quality and patient safety team.